Brahmi Herb brain boosters supplement for improve memory - neomart@gmail.com
Brahmi Herb. Regular exercise can help protect you from heart disease and stroke, high blood pressure, noninsulin-dependent diabetes, obesity, back pain, osteoporosis, and can improve your mood and help you to better manage stress.
Benefits of Bacopa / Brahmi
Bacopa is most commonly used to get better mental alertness, and enhance learning and academic performance.
Bacopa improves intellect, consciousness, and mental acuity.
Bacopa calms the mind and promotes relaxation.
Bacopa raises protein synthesis and activity in brain cells.
Bacopa improves memory, mental clarity and longevity.
Bacopa decreases anxiety, restlessness, and senility.
Brahmi Plant (Bacopa monnieri) is a medicinal plant used since 5000 BC that has been used in traditional Indian medicine as a nerve tonic to fight stress, to improve memory/mental health & to promote youthful vitality and longevity. Brahmi is used for Alzheimer's disease, anxiety, attention deficit-hyperactivity disorder allergic conditions, irritable bowel syndrome โรคลำไส้แปรปรวน หรือเรียกย่อว่า โรคไอบีเอส (IBS, Irritable bowel syndrome หรือ อาจเรียกว่า Spastic colon) . People also take brahmi to treat backache, hoarseness [n.] (เสียง) แหบห้าว คำอ่าน โฮซ-เน็ซ, mental illness, epilepsy(เอพ’พะเลพซี) n. โรคลมบ้าหมู, joint pain, and sexual performance problems in both men and women. For treatment of loss of memory take around 10 grams of Brahmi leaves & cook it with pure Ghee as shown in the video or also can be taken with honey & Ghee, Brahmi juice can also be taken with milk (say around 100 ml. of milk with 25ml. of Brahmi juice).
Warning: The viewer/reader of this video/documentation should exercise all precautionary measures while following instructions on the home remedies from this video. This information is solely for informational purposes. IT IS NOT INTENDED TO PROVIDE MEDICAL ADVICE and should not be treated as a substitute for the medical advice of your own doctor.
A number of recent scientific studies have suggested that Brahmi helps in Improving Intellect.
FAQ
How Long Does A Bottle Last?
The capsules come packed in boxes of 60 units each, each should last for around 2 weeks, for one person. .
How long till I see outcome?
In mild cases of memory troubles, outcome can be seen within 3-4 days of consumption. For more severe cases of memory interrelated problems, more than a few weeks may be required to see effective results. We recommend 2 months of supply for observing successful long-term improvement.
What is the recommended dosage?
For Adults, 2 capsules in morning and evening later than meals. Most excellent if taken with milk
Is it safe to use all through work?
Yes! Brahmi has tranquilizing effects but, unlike synthetic sedatives which often have side effects of dulling the mind, it actually improves mental clarity. So infect it improve your attentiveness in when you are working under stress, particularly through exam days.
Is it safe for Children ?
Brahmi or Bacopa has no damaging effects and is totally safe for children.
Testimonial
"In Fact I had recently heard about Brahmi a natural herb to boost the memory power. Actually I wanted to use it as a memory booster and longevity of the brain. I started using this product for around 3 months back and since one month, Now I am feeling fresh and adequately now my mood is also good as compared to before. Thanks to Brahmi" - Steve Broadmon, Australia "
Effect of Brahmi
Bacopa grows in marshy places and is cultivated in South India . It is Diuretic, Cardiac, Nervine and Tonic. It is reported to get better intellect, treatment of asthma, hoarseness, insanity, epilepsy. It is a potent nervous tonic and is anti anxiety agent. It is considered excellent for the heart.
The complete plant is used for medicinal purpose. This herb is used to get better the process of learning, restore memory, improve the power of speech and imagination, ease nervous and mental strain, and is employed in cases of insanity, epilepsy, hysteria, aesthenia, and nervous breakdowns. Taking Brahmi can assist you in experiencing a better sense of well-being during periods of restlessness, anxiety, insomnia, fatigue, cloudiness of thought, and an overactive mind. Very useful in the cure of Attention Deficit Disorder, this herb induces a sense of calm and peace while facilitating concentration by stimulating neural activity. It is also used as a blood cleanser and is considered useful for any inflammations, chronic skin diseases, high fevers, hair loss, and with controlling blood pressure.
Bacopa Contraindications, Toxicity, Cautions, and Safety
To date, no side effects have been reported with Bacopa. As with all dietary or herbal supplements, you should inform your health care professional that you are using this product. Women who are pregnant or nursing are advised to consult with a physician prior to use although medical literature has not reported any adverse effects related to fetal development during pregnancy or to infants who are breast-fed. This herb has been used safely by healthy people of all ages in India, and Brahmi tea is actually given to infants starting in their first month of life to encourage optimal brain development.
Indication
Anxiety
Hypertension
Insomnia
Decreased mental performance
Loss of memory
Depression
Nervine weakness
Behavior disorders
Brahmi is an outstanding nervine tonic used for raising the mental performance. It helps in concentration, comprehension, recall and alertness, brahmi is particularly beneficial as it aids in categorizing information in brain and its subsequent expression.
Bacopa is also called as a natural antioxidant which may give details its neuroprotective role seen in the memory centres of the brain. Just 100mg of the take out has a stronger antioxidant action than 5 times the recommended every day dose of vitamin E. Indeed animal studies at the Institute of Medical Sciences in India show that bacosides raise local reserves of powerful antioxidant enzymes similar to glutathione, catalase and super oxide dismutase which mop up free radicals. This helpful surge in free-radical scavengers spares sensitive memory-critical sites in the brain similar to the frontal cortex, striatum and hippocampus (where memories are created) from oxidative damage common in Parkinson's, dementia, depression and even aging. In particular the hippocampus dubbed "the seat of memory" appears to be selectively protected at its synapses (nerve junctions) by bacosides which is very exciting because this is where conventional neuroprotective drugs similar to Deprenyl and Centrophenoxine fail to act.
This article has been cited by other articles in PMC.
Arvid Carlsson was born in Uppsala, Sweden in 1923. Dr. Carlsson, a pharmacologist, is best known for his contributions on the neurotransmitter, dopamine, for which he won the Nobel Prize in 2000 for Medicine/Physiology. The co-recipients were Dr. Eric Kendel and Dr. Paul Greengard.
Dr. Carlsson entered Medical School in 1941 and his education was interrupted by several years of service in the Swedish armed forces. In 1951, he finished the M.L. degree, now equivalent to M.D. in North America. Later, he became a Professor at the University of Lund. In 1959, he moved to Goteborg University.
In 1957, Dr. Carlsson showed that dopamine was a neurotransmitter in the brain and not just a precursor of norepinephrine.[1] This was the prevailing view at that time. He also developed an assay to measure dopamine in the brain and found that the highest regional concentration existed in the basal ganglia. This finding led to his experiments on reserpine, which depleted dopamine and produced a loss of movement control. These symptoms were similar to the clinical symptoms seen in the neurological illness, Parkinsonism.[2,3] He did not end his investigations there, and showed that L-dopa, a precursor of dopamine, was effective treat symptoms of Parkinsonism. L-dopa is still one of the mainstays of drug treatment in Parkinsonism.
Dr. Carlsson was also instrumental in developing the ‘dopamine theory of schizophrenia’[4,5] and the role of dopamine in the development of extrapyramidal side-effects of antipsychotic medications. Inhibition of central dopamine function is a basic property common to many to antipsychotic drugs. The mesolimbic and nigrostriatal portions of the dopaminergic system are probably the main targets for the psychological and the extrapyramidal actions, respectively, of these drugs. The fact that dopaminergic hyperfunction induced by amphetamines or L-dopa may lead to a disturbance mimicking paranoid schizophrenia, further supporting the role of dopamine in mental function. Although a primary disturbance in dopamine function in schizophrenia cannot be ruled out, the intimate relationship between dopaminergic and other neuronal systems should be studied in more detail. The possible involvement of other amine, amino acid or peptide transmitters in schizophrenia cannot be disregarded. For example, there is now a large body of evidence supporting dysfunction of the glutamate receptors in schizophrenia.
Dr. Carlsson was also among the first researchers of the antidepressant compound, zimeldine, which was the first selective serotonin re-uptake inhibitor. The precursor of this drug was brompheniramine. Here, one should note that he did substantial work on the synthesis and metabolism of 5-hydroxytryptamine (serotonin) in the central nervous system.[6] However, zimeldine produced a serious neuro logical side-effect, Guillian-Barre syndrome, in a few patients and thus was withdrawn from the market. Thirteen cases of the Guillain-Barre syndrome were reviewed in an article in which the authors showed that all occurred with a similar relationship to treatment with zimeldine. The risk of developing Guillain-Barre syndrome was increased about 25-fold among patients receiving zimeldine, as compared with the natural incidence of the disorder. These cases substantiate strong evidence that Guillain-Barre syndrome may occur as a specific, probably immunologically mediated, complication of drug therapy.[7]
In the aging brain, there is a reduction of the levels of several transmitter substances and of the activities of enzymes involved in their synthesis and/or catabolism.[8] Carlsson stated that the sensitivity to the aging process varies for different transmitters and brain regions and that the dopamine neurons were more age-sensitive than most other neurons investigated by him. The metabolism of monoaminergic neurotransmitters is increased in the aging brain, as seen by increased metabolite/neurotransmitter ratios, and he suggested that this may compensate for the loss of the transmitter. In various types of dementia, including Alzheimer's disease (AD) and senile dementia of Alzheimer type (SDAT), there is a decrease in levels of several neurotransmitters as compared to age-matched controls. Recently observed changes in the lipid composition of the white matter, indicating demyelination, in the brains of patients with AD/SDAT, stress the importance of studying multifactorial aspects of dementia. Dr. Carlsson also emphasized that preventive measures may reduce the toxicity of oxygen and of autoxidation products in the brain.[9]
It is interesting to note that Dr. Carlsson opposed fluoridation of water as it is a violation of modern pharmacological principles, and he succeeded in his campaign along with hundreds of other scientists. It is also important to note that the incidence of dental caries was the same in Sweden as compared to fluoridated countries such as the USA. As British Columbia in Canada was considering fluoridation of water, Carlsson said, ‘I would advise against fluoridation. He reiterated that individual prophylaxis (treatment) is preferable on principle grounds and that it is equally effective’.[10]
1. Carlsson A. Thirty years of dopamine research. Adv Neurol. 1993;60:1–10.[PubMed]
2. Carlsson A. Basic concepts underlying recent developments in the field of Parkinson's disease. Contemp Neurol Series. 1971;8:1–31. [PubMed]
3. Carlsson A. Speculations on the control of mental and motor functions by dopamine-modulated cortico-striato-thalamo-cortical feedback loops. Mount Sinai J Med. 1988;55:6–10. [PubMed]
4. Carlsson A. Does dopamine play a role in schizophrenia? Psychol Med.1977;7:583–97. [PubMed]
5. Carlsson A. Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry. 1978;135:165–73. [PubMed]
6. Carlsson A, Bedard P, Lindqvist M, Magnusson T. The influence of nerve-impulse flow on the synthesis and metabolism of 5-hydroxytryptamine in the central nervous system. Biochem Soc Symp. 1972. pp. 17–32. [PubMed]
7. Fagius J, Osterman PO, Siden A, Wiholm BE. Guillain-Barre syndrome following zimelidine treatment. J Neurol Neurosurg Psychiatry. 1985;48:65–9.[PMC free article][PubMed]
8. Carlsson A. Brain neurotransmitters in aging and dementia: Similar changes across diagnostic dementia groups. Gerontology. 1987;33:159–67. [PubMed]
9. Carlsson A, Adolfsson R, Aquilonius SM, Gottfries CG, Oreland L, Svennerholm L, et al. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. Adv Biochem Psychopharmacol. 1980;23:295–304. [PubMed]
